Atai, Awakn make progress on treatments for alcohol use disorder

https://s43720.pcdn.co/wp-content/uploads/2024/05/psychedelics-mushrooms-and-brain.jpg

Psychedelic drug treatment companies are racing to find a cure for alcohol use disorder or alcoholism. This week, atai Life Sciences gave investors an update on its DMT-based drug, while Awakn Life Sciences updated the market on its ketamine-based drug for the same disorder.

The World Health Organization estimates that around…

Please login to read all 574 words.

Leave a Reply

Your email address will not be published. Required fields are marked *